Skip to content
The Kids Research Institute Australia logo
Donate

Search

Research

Core Competencies and Reporting Guidelines for Co-research with Adolescents (The C3 Study)

The C3 Study is an exploration into best practice around co-research with youth consumers being led by the Adolescent Health and Wellbeing Team at The Kids Research Institute Australia, who are based in Adelaide.

Research

Determinants of incomplete vaccination and non-vaccination among WA children

Tom Snelling BMBS DTMH GDipClinEpid PhD FRACP Head, Infectious Disease Implementation Research 08 6319 1817 tom.snelling@thekids.org.au Head,

Research

Determinants of prenatal alcohol exposure among Aboriginal women in the Pilbara: Developing a statistically validated model of prenatal alcohol consumption for evidence based intervention development

Investigators: Dave Tucker (PhD candidate), Associate Professor Roz Walker, Dr Martyn Symonds, Dr Nyanda McBride The overarching aim of the proposed

Research

Developing a ‘Food Atlas’ for Western Australia to map, measure and monitor food access

This unique interdisciplinary project, funded by Healthway, aims to develop a Food Atlas tool for mapping, measuring, and monitoring food access across Western Australia.

Research

Developing a human challenge model of GAS infection

NHMRC funding has been awarded for 4 years to Murdoch Childrens Research Institute for this project, with collaboration from Professor Jonathan Carapetis at The Kids.

Research

Developing and characterising juvenile models of aggressive paediatric brain cancers for the evaluation of novel immunotherapies.

While profound treatment responses have been realised using immunotherapy for some cancer types, this is yet to be seen for paediatric brain cancer patients.

Research

Developing new immune based therapies for neuroblastoma

Neuroblastoma is a complex childhood cancer of the nerve cells and the most common solid tumour in children outside of the brain. The average age of diagnosis is 1-2 years and tragically 50% of children with high-risk neuroblastoma lose their battle within five years.